First Recreational Cannabis Dispensary Opens on Long Island
Long Island opened up its first recreational dispensary.
Recently, Long Island welcomed its first cannabis dispensary targeted for recreational use. The stores’ location is in East Farmingdale and is called “Strain Stars” (1).
It is a family-owned business and becomes the 19th cannabis dispensary to open its doors in New York. The Empire State legalized recreational cannabis in 2021 but surprisingly, only 4 towns on Long Island have accepted to permit retail stores.
New York State has given priority for licenses to individuals with a prior cannabis conviction or to their relatives.
Reference
- Long Island’s First Recreational Marijuana Dispensary Opens Up in East Farmingdale https://abc7ny.com/long-island-marijuana-dispensary-ny-dispensaries/13479278/ (accessed Jul 11, 2023).
Best of the Week: May 9 – May 15, 2025
May 16th 2025Here, we bring you our top five recent articles covering cannabis legalization bills in Pennsylvania and Virginia, hemp regulation compliance in California, the first map of tribal cannabis and hemp programs, and a study on cannabis consumption and a sedentary lifestyle.
Ep 25: Cannabis Quality Differentiation Beyond Cannabinoid Content
February 28th 2025In this latest installment of Noid Knowledge we are joined by Julie Kowalski, a leading mind in analytical chemistry and cannabis testing. Julie has arranged a very compelling symposium for Pittcon entitled Cannabis Aroma: Advances and Challenges in Determining and Commercializing Cannabis Product Quality Attributes. It is taking place on Wednesday, March 5, 2025, starting at 9:30 AM in room 209. The session features top notch speakers, including several previous guests of this show, and yours truly, discussing the next generation of quality assessment in cannabis.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
